Recently, our group demonstrated that the fibroblast growth factor receptor (FGFR) pathway functions as a dominant driver in a subset of HNSCC cell lines that are inherently insensitive to EGFR-specific TKIs [14]. Here, EGFR is linked to head and neck squamous cell carcinoma.